Search results
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%
Simply Wall St. via Yahoo Finance· 7 days agoMerck's stock price might be vulnerable to their trading decisions A total of 25 investors have a...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 3 days agoWinrevair (sotatercept) was approved for pulmonary arterial hypertension (PAH, WHO Group 1) in March...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 3 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Merck Earnings Preview: Strong quarter expectations on the back of core products' growth
Seeking Alpha· 4 days agoMerck (NYSE:MRK) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 4 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 6 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for Merck & Co., Inc ...
Scholz Gets Another Pharma Boost With New Merck KGaA Site
Bloomberg· 3 days agoMerck KGaA became the latest pharma company to begin construction of a new center in Germany,...
11 Hot Growth Stocks To Buy Right Now
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we discuss the 11 hot growth stocks to buy now. If you want to read about some more growth stocks that are active in the market, go...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 3 days agoAbbVie is a #3 Ranked stock. The Zacks Consensus Estimate for 2024 EPS has declined from $11.13 per...
Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $131.25
ETF DAILY NEWS· 6 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms that are presently covering the stock ...